Observation of the effect of acarbose tablets combined with insulin in the treatment of elderly patients with type 2 diabetes
10.3760/cma.j.issn.1008-6706.2014.11.028
- VernacularTitle:阿卡波糖联合胰岛素治疗老年人2型糖尿病疗效观察
- Author:
Weijian ZHANG
;
Xiaojuan SUN
- Publication Type:Journal Article
- Keywords:
Diabetes,type 2;
Aged;
Acarbose;
Protamine zinc recombinant lai pulp mixing insulin injection
- From:
Chinese Journal of Primary Medicine and Pharmacy
2014;21(11):1665-1667
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of acarbose tablets combined with protamine zinc recombinant lai pulp mixing insulin injection in the treatment of elderly patients with type 2 diabetes.Methods 170 elderly patients with type 2 diabetes were randomly divided into the observation group and the control group.85 cases in the observation group were given acarbose tablets combined with protamine zinc recombinant lai pulp mixing insulin injection,85 cases in the control group received aspart 30.The patients were followed up for 12 weeks,the blood glu cose levels,blood glucose fluctuation,glycosylated hemoglobin (HbAlc),the incidence of hypoglycemia and insulin dosage were observed.Results' The level of fasting plasma glucose (FPG) (t =9.92,P ＜ 0.05),2h postprandial blood glucose(2hPG) (t =18.18,P ＜0.05),the mean blood glucose within 4h(t =13.62,P ＜0.05),days of average blood glucose fluctuations (t =14.56,P ＜ 0.05) of observation group dropped significantly compared with that before treatment;HbAlc achieved rate(6.5％)of the observation group and control group were 35.29％,28.23％,re spectively,HbAlc achieved rate (7.0％) of observation group and control group were 57.64％,52.94％,the differences were not statistically significant(all P ＞ 0.05).The dose of insulin was significantly lower in the observation group(20.11 ±3.36) u/d than(35.78 ±4.68) u/d in the control group(t =25.08,P ＜0.01).There were 2 cases of hypoglycemic events and 3 cases in the control group.Conclusion Protamine zinc recombinant insulin lispro injection combined with acarbose has reliable clinical efficacy and safety.
